Renaissance Technologies’s Astria Therapeutics ATXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.55M Buy
289,778
+110,617
+62% +$593K ﹤0.01% 2267
2025
Q1
$957K Buy
+179,161
New +$957K ﹤0.01% 2454
2024
Q4
Sell
-38,061
Closed -$419K 3562
2024
Q3
$419K Buy
38,061
+15,600
+69% +$172K ﹤0.01% 2861
2024
Q2
$204K Sell
22,461
-18,939
-46% -$172K ﹤0.01% 3042
2024
Q1
$583K Buy
41,400
+27,200
+192% +$383K ﹤0.01% 2798
2023
Q4
$109K Buy
14,200
+4,100
+41% +$31.5K ﹤0.01% 3286
2023
Q3
$75K Sell
10,100
-80,961
-89% -$601K ﹤0.01% 3305
2023
Q2
$759K Buy
91,061
+42,761
+89% +$356K ﹤0.01% 2642
2023
Q1
$642K Sell
48,300
-33,961
-41% -$451K ﹤0.01% 2742
2022
Q4
$1.23M Buy
82,261
+24,400
+42% +$363K ﹤0.01% 2408
2022
Q3
$523K Buy
57,861
+44,161
+322% +$399K ﹤0.01% 2905
2022
Q2
$41K Buy
+13,700
New +$41K ﹤0.01% 4025
2022
Q1
Sell
-34,361
Closed -$185K 4067
2021
Q4
$185K Sell
34,361
-74,992
-69% -$404K ﹤0.01% 3538
2021
Q3
$967K Buy
109,353
+46,443
+74% +$411K ﹤0.01% 2571
2021
Q2
$796K Buy
62,910
+33,067
+111% +$418K ﹤0.01% 2777
2021
Q1
$517K Buy
+29,843
New +$517K ﹤0.01% 2895
2020
Q3
Sell
-17,341
Closed -$669K 3364
2020
Q2
$669K Buy
17,341
+7,953
+85% +$307K ﹤0.01% 2755
2020
Q1
$234K Sell
9,388
-5,886
-39% -$147K ﹤0.01% 3057
2019
Q4
$542K Buy
15,274
+9,240
+153% +$328K ﹤0.01% 2873
2019
Q3
$196K Sell
6,034
-5,269
-47% -$171K ﹤0.01% 3155
2019
Q2
$547K Sell
11,303
-9,391
-45% -$454K ﹤0.01% 2957
2019
Q1
$983K Buy
20,694
+14,741
+248% +$700K ﹤0.01% 2674
2018
Q4
$156K Sell
5,953
-1,609
-21% -$42.2K ﹤0.01% 3178
2018
Q3
$363K Sell
7,562
-6,353
-46% -$305K ﹤0.01% 2956
2018
Q2
$801K Sell
13,915
-1,955
-12% -$113K ﹤0.01% 2687
2018
Q1
$1.72M Buy
15,870
+8,058
+103% +$875K ﹤0.01% 2405
2017
Q4
$698K Buy
7,812
+4,889
+167% +$437K ﹤0.01% 2802
2017
Q3
$372K Buy
2,923
+1,015
+53% +$129K ﹤0.01% 2858
2017
Q2
$161K Buy
1,908
+806
+73% +$68K ﹤0.01% 3031
2017
Q1
$106K Buy
+1,102
New +$106K ﹤0.01% 3077